http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SK-278141-B6

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-72
filingDate 1988-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28c7160798c23f4a385b782221e78540
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf8d5b20bd39a59f943432aa975f2c67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d103d5601c646c290577a1a27ee08402
publicationDate 1996-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SK-278141-B6
titleOfInvention Enolether amide 1,1-dioxo-6-chloro-4-hydroxy-2-methyl-n- -(2-pyridyl)-2h-thieno(2,3-e)1,2-thiazine-3-carboxylic acid, method of its production and pharmaceutical agent
abstract Compound of general formula I, is prepared from corresponding 4-hydroxyderivative-chlorothenoxicame with additing at least one equivalent of base with contents of alkaline metal, advantageously 3 to 4 multiple surplus of this base in polar aprotic solvent, inert by reaction conditions, by room temperature to boiling point of reactive solvent under reversible cooler, at which formated salt is parallels introduced to reaction with compound of formula IIIa, for alleviate of reaction is into rea1ctive mixture additing sodium iodide in tiple surplus, with regard on alkylating agent.
priorityDate 1987-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID162095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420178106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448906802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406917592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21191674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457493163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419802385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499578
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409432392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2176

Total number of triples: 33.